A multicentre, double-blind, randomized, placebo-controlled, parallel group trial to investigate the efficacy and safety of lacosamide (200, 400 or 600 mg/day) as adjunctive therapy in subjects with partial seizures.

Trial Profile

A multicentre, double-blind, randomized, placebo-controlled, parallel group trial to investigate the efficacy and safety of lacosamide (200, 400 or 600 mg/day) as adjunctive therapy in subjects with partial seizures.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2015

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Partial epilepsies
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top